<SEC-DOCUMENT>0001193125-13-368442.txt : 20130917
<SEC-HEADER>0001193125-13-368442.hdr.sgml : 20130917
<ACCEPTANCE-DATETIME>20130917062735
ACCESSION NUMBER:		0001193125-13-368442
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20130917
FILED AS OF DATE:		20130917
DATE AS OF CHANGE:		20130917

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AEGON NV
		CENTRAL INDEX KEY:			0000769218
		STANDARD INDUSTRIAL CLASSIFICATION:	LIFE INSURANCE [6311]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10882
		FILM NUMBER:		131099982

	BUSINESS ADDRESS:	
		STREET 1:		AEGONPLEIN 50
		STREET 2:		PO BOX 85
		CITY:			THE HAGUE
		STATE:			P7
		ZIP:			2501 CB
		BUSINESS PHONE:		011-31-70-344-7308

	MAIL ADDRESS:	
		STREET 1:		AEGONPLEIN 50
		STREET 2:		PO BOX 85
		CITY:			THE HAGUE
		STATE:			P7
		ZIP:			2501 CB
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d592600d6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML><HEAD>
<TITLE>FORM 6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Securities and Exchange Commission
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Form 6-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Report of Foreign Issuer </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant to Rule 13a-16 or 15d/16 of </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>September 2013 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>AEGON N.V.
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Aegonplein 50 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2591 TV
THE HAGUE </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The Netherlands </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aegon&#146;s press release, dated September&nbsp;17, 2013, is included as appendix and incorporated herein by
reference. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SIGNATURE </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">AEGON N.V.</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">(Registrant)</TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date: September 17, 2013</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">By</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ E. Lagendijk</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">E. Lagendijk</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Executive Vice President and</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">General Counsel</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g592600img1.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Press release </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">The Hague &#150; September&nbsp;17, 2013 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Aegon to repurchase shares to neutralize stock dividend </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aegon announces that it will repurchase approximately 19&nbsp;million common shares to neutralize the dilutive effect of the 2013 interim dividend paid in
shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Approximately 55% of shareholders have elected to receive the cash dividend. The remaining 45% have opted for stock dividend. As a result,
19,047,358 new common shares were issued on September&nbsp;13, 2013. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Aegon has committed itself irrevocably to the repurchase of these common shares by
engaging a third party to execute the transactions on its behalf, which are expected to be completed before October&nbsp;16, 2013. Under the agreement, Aegon will repurchase shares at the daily volume-weighted average price. Aegon will provide a
weekly update regarding the transactions on its website <U>www.aegon.com/sharebuyback</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At the next Annual General Meeting on May&nbsp;21, 2014, Aegon
will seek approval from its shareholders to cancel all common shares repurchased as part of this program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>News releases, financial calendar and other
corporate publications can also be found in Aegon&#146;s investor and media app. </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Media relations</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Investor relations</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Robin Boon</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Willem van den Berg</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">+ 31 (0)&nbsp;70 344 8956</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">+ 31 (0) 70 344 8305</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><U>gcc@aegon.com</U></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><U>ir@aegon.com</U></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g592600img1.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>DISCLAIMERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-looking statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The statements contained in
this document that are not historical facts are forward-looking statements as defined in the US Private Securities Litigation Reform Act of 1995. The following are words that identify such forward-looking statements: aim, believe, estimate, target,
intend, may, expect, anticipate, predict, project, counting on, plan, continue, want, forecast, goal, should, would, is confident, will, and similar expressions as they relate to Aegon. These statements are not guarantees of future performance and
involve risks, uncertainties and assumptions that are difficult to predict. Aegon undertakes no obligation to publicly update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking
statements, which merely reflect company expectations at the time of writing. Actual results may differ materially from expectations conveyed in forward-looking statements due to changes caused by various risks and uncertainties. Such risks and
uncertainties include but are not limited to the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Changes in general economic conditions, particularly in the United States, the Netherlands and the United Kingdom; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Changes in the performance of financial markets, including emerging markets, such as with regard to: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The frequency and severity of defaults by issuers in Aegon&#146;s fixed income investment portfolios; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The effects of corporate bankruptcies and/or accounting restatements on the financial markets and the resulting decline in the value of equity and debt securities Aegon holds; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The effects of declining creditworthiness of certain private sector securities and the resulting decline in the value of sovereign exposure that Aegon holds; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Changes in the performance of Aegon&#146;s investment portfolio and decline in ratings of Aegon&#146;s counterparties; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Consequences of a potential (partial) break-up of the euro; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The frequency and severity of insured loss events; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Changes affecting mortality, morbidity, persistence and other factors that may impact the profitability of Aegon&#146;s insurance products; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Reinsurers to whom Aegon has ceded significant underwriting risks may fail to meet their obligations; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Changes affecting interest rate levels and continuing low or rapidly changing interest rate levels; changes affecting currency exchange rates, in particular the EUR/USD and EUR/GBP exchange rates; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Changes in the availability of, and costs associated with, liquidity sources such as bank and capital markets funding, as well as conditions in the credit markets in general such as changes in borrower and counterparty
creditworthiness; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Increasing levels of competition in the United States, the Netherlands, the United Kingdom and emerging markets; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Changes in laws and regulations, particularly those affecting Aegon&#146;s operations, ability to hire and retain key personnel, the products Aegon sells, and the attractiveness of certain products to its consumers;
</TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Regulatory changes relating to the insurance industry in the jurisdictions in which Aegon operates; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Changes in customer behavior and public opinion in general related to, among other things, the type of products also Aegon sells, including legal, regulatory or commercial necessity to meet changing customer
expectations; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Acts of God, acts of terrorism, acts of war and pandemics; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Changes in the policies of central banks and/or governments; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Lowering of one or more of Aegon&#146;s debt ratings issued by recognized rating organizations and the adverse impact such action may have on Aegon&#146;s ability to raise capital and on its liquidity and financial
condition; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Lowering of one or more of insurer financial strength ratings of Aegon&#146;s insurance subsidiaries and the adverse impact such action may have on the premium writings, policy retention, profitability and liquidity of
its insurance subsidiaries; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The effect of the European Union&#146;s Solvency II requirements and other regulations in other jurisdictions affecting the capital Aegon is required to maintain; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Litigation or regulatory action that could require Aegon to pay significant damages or change the way Aegon does business; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">As Aegon&#146;s operations support complex transactions and are highly dependent on the proper functioning of information technology, a computer system failure or security breach may disrupt Aegon&#146;s business,
damage its reputation and adversely affect its results of operations, financial condition and cash flows; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Customer responsiveness to both new products and distribution channels; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Competitive, legal, regulatory, or tax changes that affect profitability, the distribution cost of or demand for Aegon&#146;s products; </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Changes in accounting regulations and policies may affect Aegon&#146;s reported results and shareholders&#146; equity; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">The impact of acquisitions and divestitures, restructurings, product withdrawals and other unusual items, including Aegon&#146;s ability to integrate acquisitions and to obtain the anticipated results and synergies from
acquisitions; </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Catastrophic events, either manmade or by nature, could result in material losses and significantly interrupt Aegon&#146;s business; and </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">Aegon&#146;s failure to achieve anticipated levels of earnings or operational efficiencies as well as other cost saving initiatives. </TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further details of potential risks and uncertainties affecting Aegon are described in its filings with the Netherlands Authority for the Financial Markets and
the US Securities and Exchange Commission, including the Annual Report. These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, Aegon expressly disclaims any obligation or
undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Aegon&#146;s expectations with regard thereto or any change in events, conditions or circumstances on which any such
statement is based. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ABOUT AEGON </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As an international life
insurance, pensions and asset management company based in The Hague, Aegon has businesses in over twenty markets in the Americas, Europe and Asia. Aegon companies employ approximately 24,000 people and have millions of customers across the globe.
Further information: <U>aegon.com</U>. </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g592600img1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g592600img1.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````/```_^X`#D%D
M;V)E`&3``````?_;`(0`!@0$!`4$!@4%!@D&!08)"P@&!@@+#`H*"PH*#!`,
M#`P,#`P0#`X/$`\.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-#`T8$!`8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\``$0@`0P+&`P$1``(1`0,1`?_$`*L``0`"`@,!````````
M```````!!@0%`@,'"`$!`0`#`0$```````````````$"`P4$!A```0,"!`,$
M!@8%"0D```````$"`P0%$9-5!M$2%B$Q!Q=!(C(3E!A187&2%0B!4A0T19&A
ML4)BHB,S0\&"LE-C@R1T-1$!``$#`@0#!@4$`P$```````(!4@.1%1$$%!:A
MDE,A,4%1$@7P<2)"$V&!,@;1\3."_]H`#`,!``(1`Q$`/P#ZI```````````
M&OO=U_"Z5M4Z/WD2.1LG;@J(OI`R:*LAK*9E1"N,;TQ3[?2@'>``````````
M````````````````````````````````````````````````````````````
M```````````````````````````````85[H&U]JJ:5W^HQ</M3M3^@"L^'5=
M*Z&:BEQ]Y#[>/H5J\JH6HN9`````````````````````````````````````
M````````````````````````````````````````````````````````````
M`````*901?A.^JF'!$@N#%D8J]B(JJCG?WBBYD``````````````````````
M````````````````````````````````````````````````````````````
M````````````````````JF^5CIGVZOP_Q6S)%C_95%=_2TM!9J6=L]-',U45
M'M15P[L53M0@[0``````````````````````````````````````````````
M`````````````````````````````````````````!AW6]6FT4JU5SJXJ.G3
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M?V^P5#6IC+#A+%]K%Q7^[B*#%V)<OVJT-B54YHO9;Z<%[5Q_26HLI```````
M````````````````````````````````````````````````````````````
M`````````````````````*-XR;>_&=D5:L9S5%%_Y,7T^HG:B?:=#[9F^C-3
MY5]CF_=<'\F&OSI[7RT?8/B5Z\&K"MTWE%.^-9(+;&^J>W#'%S>QK?M57'.^
MZ9OHQ</C+V.I]IP_7FX_"/M6?QEAW/?;!M6^4],MON-+=T8D57&YONU<KTBD
M>W#'D[CY;F,=(2X4KQH^NY;)6<.,J<*KU8Z/QGI67*7=5SM-91I1S?LL=NBE
MCF2=&JK557HB8&EN4S\N\\M-X?;@N%NHVU^Y$KJEU32J](Y))D55:QSW>RB]
M@6K6MWI<:ZNWQ;JC9U-MW=BV>:HK*N"H;45#\(7<K55C41/51.Y0+_\`EV9;
M&^$]F6AY>=Z/=6JWO_:.=>;F_M88!*O(;I[J._\`C%#:</P=:%75+8_\I*C!
M_=AV!73MF6K\,K+:KNYTDNT-YVQJ5W>[]FKE9BCOJ1W,[!`/5_RQIAX3T7_L
MU/\`Q@J]5>QKV.8Y,6N145/J4(\UM%ZMFVMTUEON%9%2Q<[E_P`5R-]1_K,[
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M7N,:\MDI6E*QKQK_`$;(\]@K&LJ3C],??7C3V<6=-#'-"^*1J.CD16N:O<J*
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M3PWVEN*IOJ;VANM36P>XK4KJNED65RX\SW.YL>U'88`:RJ\,MG4M?5R[3\3G
M[9H*]ZR5-MI:RG=#S.]KD_Q6<N/Z0-[;ME^$]LV'=-I4&YJ1BWB-S;A=9*NF
MDJ9'N3VW*KD1</0@%G3PYVY=?#&DV;+4_M]J921P4]P9R.<O(F#)F*W%N/V!
M&=X<;%IMC[6@V_35<E;%"^21*B5K6.59%QPP;V=@%G`H^]O"JV;JN<=PDK)*
M.9L?NWI&QKD?@O8J\QZ<'-5Q^ZCSYN7ID]ZLN_+G9U7'\9J4_P"U&=&GWJ=/
MVT<R?V2%:\?JJA/RXV?6JG*C+O<[:,-AA=7P3\N=GUFIRHQO<K:+L4+J^"%_
M+C9M9J<N,;W.VC&OV"%?W5$_+E9M9J<N,N]SMH;!"ZJ?ESL^LU.7&3>YVT-@
MA=7P/ETL^LU.7&-[E;0V"%U?!/RZ6?6:G+C&]RMH;!"ZO@?+K9]9J<N,;W.V
MAV_"ZO@?+I9]9J<N,N]SMHQ[>QW53\NMGUBIRXR;W.VAV]CNJ?+M9]8J<N,;
MW.VAV]CNJGY=[1K%3EQC>YVT.WH75\#Y>+1K%3EQC>YVT.WH75\$_+S:-8J<
MN,;W.VAV]"ZO@?+S:,,/QBIRXQO<[:%?]>QU_=7P/EYL^L5.7&7>YVT8]N8[
MJI^7JT:Q4Y<8WN=M%[=QW5\#Y>K1K%3EQC>YVT3MS'?7P3\OEHU>IRXQO<[:
M';F.^O@+^7RT+_%ZC+C&]SMH5_UO'7]]?`3\OEHU>HRXQOD[:)VWCOKX)^7V
MT:O49<8WR=M#MO'?7P3\OUIU>HRXQO<[:';6.^O@)^7^TI_%ZC+C&^3MHG;6
M.^7@GR!M.KU&7&-[G;0[:QWR\#R`M../XM49<8WR=M"O^LXZ_OEX'D#:=6J,
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M\J]B\RK@WO\`U3J<K]SEAQ_32G%RN;^U1SY/JK7@V]A\*=B61S)::V,FJ&=J
M5%2JS/Q^E.?U4_0AHS?<,V3WR]G]/8WX?MN#'[H^W^OM6U&HB(U$P:B8(GHP
M/$]RCW38OA8ER>M?M>@?45"K--5R4D2L57+BYSY%3Z5])LCBK*G&C5/-2->%
M7!?#_P`%48YZV.QHQJHUSEAI\$5W<G=Z<1_#/Y5/YX74U==3L;P6IWL8[;]G
M?(][8T8RGIU7F=AACW?26."=?@QGS,(_%V^7W@M[M)?P.Q^[=BB/]S3X*K?:
M[</1Z2?PSX\.%67\\.''ZJ:N*>'_`(-R4\L]+MRT5C8419&TU-!*Y$7ZFI]1
M?X94KPK3A^9_/&M*UI7CP^7M62U7#;E';8Z:D=!;Z2CC:C*159"D,?\`53DQ
M]5!7#.E?=Q2G,0K3CQX,IE\LKV->ROIW,<[D:Y)6*BN7^JBX]_82N&?RJM,\
M*_NIJ/OME8[D?7T[78JWE65B+BBX*G?]/8*89U^%="N>%/W4U925-.J-<DK%
M1ZX,5')VJGH3Z3#Z:MGU4^;L(H``````````````````````````````````
M`````````````````````````````````````````````````````````!6]
MT_O,/L^RSVN[_-;WGKY?W5_'P>+F??3\?%7Y/_K3>UC[N7'W_?[*]WU?J_4>
MJG^%/[>YXZ_YU_O[W-V'N9/8]E<>3]W]A.[_`*GTX$^/XX_]%?=7\4_[%Y_V
MBKY_=\W(_P!OE_Y;>[D]4?"B_&OX^#9V?V*_V/W=GL?[W>:<OP_-OQ>Z7Y-3
MZV--CR<OO)N7GY</1]'K?RF_Y_V>>GP_.KCZ_NW\O)^Z1\W)RX88M_6_V=I?
M^4K[O_EV>OS4O)[KV9L>7EQPQ7OY_P"?TF/S_LR^7N^+CMCEZAI\.;'UN_F]
MW["^SB7F/_.K'E?_`%I^*/1#E.T`````````````````````````````````
K``````````````````````````````````````````````````````'_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
